Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

Why was mining firm held liable in Brazil disaster? How will Goldman Sachs' housing outlook affect 2026? What impact does Israel oppose to Palestinian state have? Why are baristas striking at Starbucks now? How will Google’s $40B Texas AI investment impact tech? Why did USPS announce planned price increases? What triggered JPMorgan’s legal battle over Frank founder?

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

benzinga.com/analyst-stock-ratings/analyst-color/25/11/48787943/analyst-sees-strong-medtronic-momentum-through-2026-with-buy-rating-intact

Medical devices giant Medtronic Plc (NYSE:MDT) is scheduled to report its second-quarter fiscal year 2026 results on Tuesday, November 18.
According to data from Benzinga Pro, analysts estimate adjusted earnings of $1.315 per share and sales of $8.865 billion.
Bank of America (BofA)…

This story appeared on benzinga.com, 2025-11-11 18:42:06.